4.5 Article

A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy

Ashwani Arya et al.

Summary: Alzheimer's disease is a gradually growing irreversible illness of the brain that affects a large population worldwide, with potential treatment options involving inhibitors of acetylcholine (ACh) to improve cholinergic transmission.

BIOMOLECULES (2021)

Article Clinical Neurology

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

Hong Xu et al.

Summary: The study showed that ChEIs are associated with a slower cognitive decline in Alzheimer's disease patients as well as a decreased risk of severe dementia or death. Galantamine was particularly effective in reducing mortality and the risk of severe dementia, while all ChEIs had a modest but persistent effect on cognitive benefits over time.

NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

A Comprehensive Review of Cholinesterase Modeling and Simulation

Danna De Boer et al.

Summary: This article reviews published research on the structure and function of acetylcholinesterase and butyrylcholinesterase using computer-based modeling and simulation techniques. It discusses similarities and differences in the active site gorges of the two enzymes, catalytic studies, inhibitory activities of various compounds, interactions with narcotics and organophosphate compounds, as well as advancements in virtual screening methodologies.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis

Lucja Justyna Walczak-Nowicka et al.

Summary: Acetylcholinesterase (AChE) plays a crucial role in the pathogenesis of neurodegenerative diseases, with ongoing research focusing on identifying new AChE inhibitors to potentially treat these diseases. The review highlights the importance of AChE inhibitors and their potential use in developing therapies for neurodegenerative diseases. Further investigations into designing and discovering new drugs targeting AChE may lead to effective treatments for neurodegenerative diseases in the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019)

Alexandre A. de Castro et al.

BIOMOLECULES (2020)

Article Chemistry, Medicinal

Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents

Catarina Oliveira et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Identification of new allosteric sites and modulators of AChE through computational and experimental tools

Carlos Roca et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)

Article Mathematical & Computational Biology

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease

Mohd. Babu Khan et al.

BIOINFORMATION (2018)

Article Chemistry, Medicinal

Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors

Zahra Najafi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Computational Studies on Acetylcholinesterases

Yechun Xu et al.

MOLECULES (2017)

Article Biochemistry & Molecular Biology

Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies

Sridevi Chigurupati et al.

BIOORGANIC CHEMISTRY (2016)

Article Biochemical Research Methods

In silico designing of hyper-glycosylated analogs for the human coagulation factor IX

Fahimeh Ghasemi et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)

Article Biochemistry & Molecular Biology

Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina

Cristiane Bezerra da Silva et al.

MOLECULES (2016)

Article Medicine, Research & Experimental

Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's

Jaspreet Kaur Dhanjal et al.

BIOMEDICINE & PHARMACOTHERAPY (2015)

Article Chemistry, Medicinal

Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors

Mariyana Atanasova et al.

MOLECULAR INFORMATICS (2015)

Article Biochemistry & Molecular Biology

Exploring the Structural Insights on Human Laforin Mutation K87A in Lafora Disease-A Molecular Dynamics Study

P. S. Srikumar et al.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2013)

Article Neurosciences

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

Mirjana B. Colovic et al.

CURRENT NEUROPHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

Acetylcholinesterase: From 3D structure to function

Hay Dvir et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2010)

Article Chemistry, Physical

GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation

Berk Hess et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)

Review Biochemistry & Molecular Biology

Allosteric regulation and catalysis emerge via a common route

Nina M. Goodey et al.

NATURE CHEMICAL BIOLOGY (2008)

Article Biochemistry & Molecular Biology

A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation

GV De Ferrari et al.

BIOCHEMISTRY (2001)